|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.50 USD | +6.33% |
|
-11.19% | -34.62% |
| 03:05pm | Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-29 | Core Laboratories Inc. Provides Earnings Guidance for the Third Quarter of 2026 | CI |
Company Valuation: Core Laboratories Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,033 | 939.9 | 825.1 | 812.7 | 746.4 | 455 | - |
| Change | - | -8.98% | -12.21% | -1.51% | -8.16% | -39.05% | - |
| Enterprise Value (EV) | 1,204 | 1,097 | 973.2 | 919.7 | 746.4 | 455 | 455 |
| Change | - | -8.87% | -11.28% | -5.5% | -18.84% | -39.05% | 0% |
| P/E | 53.1x | 48.3x | 20.5x | 26.2x | 23.6x | 24.1x | 12.8x |
| PBR | 6.47x | 5.02x | - | - | - | - | - |
| PEG | - | - | 0x | -1.1x | 7.79x | -0.6x | 0.1x |
| Capitalization / Revenue | 2.2x | 1.92x | 1.62x | 1.55x | 1.42x | 0.89x | 0.84x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.89x | 0.84x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 7.89x | 6.78x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 10.9x | 7.98x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | 0.18% | 0.2% | 0.23% | 0.23% | 0.25% | 0.41% | 0.41% |
| EPS 2 | 0.42 | 0.42 | 0.86 | 0.66 | 0.68 | 0.41 | 0.77 |
| Distribution rate | 9.52% | 9.52% | 4.65% | 6.06% | 5.88% | 9.76% | 5.19% |
| Net sales 1 | 470.3 | 489.7 | 509.8 | 523.8 | 526.5 | 510.8 | 539.5 |
| EBITDA 1 | 70.81 | 61.98 | 76.96 | 80.2 | 73.34 | 57.67 | 67.11 |
| EBIT 1 | 52.29 | 44.82 | 61.18 | 65.25 | 58.7 | 41.78 | 56.98 |
| Net income 1 | 19.73 | 19.45 | 40.94 | 31.4 | 31.8 | 18.92 | 35.42 |
| Net Debt | 170.9 | 157 | 148 | 107 | - | - | - |
| Reference price 2 | 22.310 | 20.270 | 17.660 | 17.310 | 16.030 | 9.870 | 9.870 |
| Nbr of stocks (in thousands) | 46,290 | 46,371 | 46,724 | 46,950 | 46,563 | 46,097 | - |
| Announcement Date | 02/02/22 | 01/02/23 | 31/01/24 | 29/01/25 | 04/02/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.07x | - | - | 0.41% | 455M | |
| 26.11x | 2.91x | 13.05x | 3.28% | 23.4B | |
| 43.73x | 5.77x | 21.24x | 0.63% | 18.62B | |
| 20.41x | 2.88x | 11.8x | 1.31% | 3.47B | |
| 12.98x | - | - | 2.52% | 2.17B | |
| -32.69x | 1.25x | 8.01x | -.--% | 1.6B | |
| 21.07x | - | - | 2.42% | 1.52B | |
| Average | 16.53x | 3.20x | 13.52x | 1.51% | 7.32B | |
| Weighted average by Cap. | 29.57x | 3.98x | 16.02x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLB Stock
- Valuation Core Laboratories Inc.
Select your edition
All financial news and data tailored to specific country editions
